← Back to Search

Intermittent fast for Inflammation

Phase 1

Waitlist Available

Research Sponsored by Eleah Stringer

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 3 months pre-intervention, monthly during intervention, 1 month post-intervention

Awards & highlights

Study Summary

This trial is looking at whether fasting could improve chemotherapy for cancer patients, and if it could be a way to prevent or manage cancer.

Eligible Conditions

Inflammation
Healthy Habits and Diet
Tumors
Chronic Lymphocytic Leukemia
Lymphoma
Intermittent Fasting

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 3 months pre-intervention, monthly during intervention, 1 month post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 3 months pre-intervention, monthly during intervention, 1 month post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 months pre-intervention, monthly during intervention, 1 month post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in autophagy status

Change in inflammation

Change in lymphocyte count

+3 more

Secondary outcome measures

Change in gut microbiome (optional)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intermittent fastingExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

BC Cancer FoundationOTHER

17 Previous Clinical Trials

8,344 Total Patients Enrolled

Eleah StringerLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment include elderly individuals aged 75 or above?

"This clinical trial is accepting volunteers aged 19 and up, with a maximum age limit of 85."

Answered by AI

To whom is this clinical trial open for participation?

"To gain admittance to this medical trial, candidates must have cancer and be between 19 and 85 years in age. The total number of participants accepted will amount to around 15 people."

Answered by AI

Are there any government endorsements of intermittent fasting?

"With limited clinical evidence, Intermittent Fast was assigned a score of 1 upon our team's evaluation. This indicates that this intervention is currently in its earliest testing stages."

Answered by AI

Are participants being accepted to join this clinical research initiative?

"As per clinicaltrials.gov, this study is not currently seeking any more participants. The trial was first activated on February 3rd 2021 and last revised on March 15th 2022. Although the current investigation is no longer recruiting patients, there are 5431 other research projects that are open for enrollment at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Intermittent Fasting and CLL/SLL

Eleah Stringer 2021. "Intermittent Fasting and CLL/SLL". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04626843.